<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37977479</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8541</ISSN><JournalIssue CitedMedium="Internet"><Volume>576</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of theoretical biology</Title><ISOAbbreviation>J Theor Biol</ISOAbbreviation></Journal><ArticleTitle>Modeling long COVID dynamics: Impact of underlying health conditions.</ArticleTitle><Pagination><StartPage>111669</StartPage><MedlinePgn>111669</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtbi.2023.111669</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5193(23)00266-7</ELocationID><Abstract><AbstractText>We propose a new mathematical model to investigate the population dynamics of long COVID, with a focus on the impact of chronic health conditions. Our model connects long COVID with the transmission of COVID-19 so as to accurately predict the prevalence of long COVID from the progression of the infection in the host population. The model additionally incorporates the effects of COVID-19 vaccination. We implement the model with data from both the US and the UK to demonstrate the real-world applications of this modeling framework.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Mathematics and Statistics, Liaoning University, Shenyang 110036, China. Electronic address: linlanfaith@aliyun.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Mathematics, University of Tennessee at Chattanooga, Chattanooga TN 37403, USA. Electronic address: jin-wang02@utc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R15 GM152943</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Theor Biol</MedlineTA><NlmUniqueID>0376342</NlmUniqueID><ISSNLinking>0022-5193</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011157" MajorTopicYN="N">Population Dynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic conditions</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mathematical modeling</Keyword></KeywordList><CoiStatement>Declaration of competing interest We declare that there is no conflict of interest in this work. We also confirm that this paper has not been published elsewhere and that it is not under consideration for publication by another journal.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>18</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>19</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37977479</ArticleId><ArticleId IdType="mid">NIHMS1951426</ArticleId><ArticleId IdType="pmc">PMC10754059</ArticleId><ArticleId IdType="doi">10.1016/j.jtbi.2023.111669</ArticleId><ArticleId IdType="pii">S0022-5193(23)00266-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Afzal A, Saleel CA, Bhattacharyya S, Satish N, Samuel OD, Badruddin IA, 2022. Merits and limitations of mathematical modeling and computational simulations in mitigation of COVID-19 pandemic: A comprehensive review. Arch. Comput Methods Eng 29 (2), 1311&#x2013;1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356220</ArticleId><ArticleId IdType="pubmed">34393475</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B, 2021. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA, Johnson L, 2021. Defining long COVID: Going back to the start. Med. (N Y) 2 (5), 501&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7992371</ArticleId><ArticleId IdType="pubmed">33786465</ArticleId></ArticleIdList></Reference><Reference><Citation>Anon, 2022. Department of Health and Human Services, Office of the Assistant Secretary for Health, National Research Action Plan on Long COVID.</Citation></Reference><Reference><Citation>Anon, 2023a. Centers for Disease Control and Prevention: Post-COVID conditions. Available at https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html.</Citation></Reference><Reference><Citation>Anon, 2023b. Hamilton County Health Department. Available at: https://health.hamiltontn.org.</Citation></Reference><Reference><Citation>Anon, 2023c. Hamilton County Health Department: COVID-19 Vaccination Reporting. Available at https://health.hamiltontn.org/en-us/allservices/coronavirus(covid-19).aspx.</Citation></Reference><Reference><Citation>Anon, 2023d. Tennessee Department of Health: Coronavirus Disease (COVID-19)
Available at https://www.tn.gov/health/cedep/ncov.html.</Citation></Reference><Reference><Citation>Anon, 2023e. Office for National Statistics: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. Available at https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/.</Citation></Reference><Reference><Citation>Anon, 2023f. World Health Organization: Coronavirus disease (COVID-19) situation reports. Available at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.</Citation></Reference><Reference><Citation>Bergwerk M, Gonen T, Lustig Y, et al., 2021. Covid-19 breakthrough infections in vaccinated health care workers. N. Engl. J. Med 385 (17), 1629&#x2013;1630.</Citation><ArticleIdList><ArticleId IdType="pubmed">34587379</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K, Montenegro-Jim&#xe9;nez Y, Torres-Castro R, et al., 2021. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease. Chronic Respiratory Dis. 18, 14799731211002240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, et al., 2022. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nature Commun. 13 (1), 446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A, 2021. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. Lancet Microbe 2 (1), e13&#x2013;e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837230</ArticleId><ArticleId IdType="pubmed">33521734</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, et al., 2020. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying. Lancet Glob. Health 8, e1003&#x2013;e1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295519</ArticleId><ArticleId IdType="pubmed">32553130</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al., 2021. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H, Strasser ZH, Brat GA, Semenov YR, 2021. Consortium for characterization of COVID-19 by EHR (4CE), C.J. Patel, and S.N. Murphy, evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Med. 19, 249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kates J, Dawson L, Anderson E, et al., 2021. COVID-19 Vaccine Breakthrough Cases: Data from the States. Kaiser Family Foundation.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, Navarro-Santana M, 2021. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Int. Med 92, 55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Le&#xf3;n S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S, 2021. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep 11, 16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M, 2021. The four most urgent questions about long COVID. Nature 594, 168&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">34108700</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C, Luteijn M, Letton W, Robertson J, McDonald S, 2021. A model framework for projecting the prevalence and impact of long-COVID in the UK. PLoS One 16 (12), e0260843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8639065</ArticleId><ArticleId IdType="pubmed">34855874</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey D, Berrent D, Krumholz H, 2021. Breakthrough Symptomatic COVID-19 Infections Leading to Long Covid: Report from Long Covid Facebook Group Poll. 10.1101/2021.07.23.21261030, medRxiv.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.23.21261030</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al., 2021. Post-acute COVID-19 syndrome. Nat. Med 27, 601&#x2013;615</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Napolitano F, Xu X, Gao X, 2022. Impact of computational approaches in the fight against COVID-19: An AI guided review of 17, 000 studies. Brief. Bioinform 23 (1), bbab456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689952</ArticleId><ArticleId IdType="pubmed">34788381</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmanabhan R, Abed HS, Meskin N, Khattab T, Shraim M, Al-Hitmi MA, 2021. A review of mathematical model-based scenario analysis and interventions for COVID-19. Comput. Methods Programs Biomed 209, 106301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314871</ArticleId><ArticleId IdType="pubmed">34392001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, et al., 2022. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit. Health 4 (7), e532&#x2013;e541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB, 2021. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol 12, 698169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman A, Kuddus MA, 2021. Modelling the transmission dynamics of COVID-19 in six high-burden countries. BioMed Res. Int 2021, 5089184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172286</ArticleId><ArticleId IdType="pubmed">34124240</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzaghi H, Wang Y, Lu H, Marshall KE, Dowling NF, Paz-Bailey G, et al., 2020. Estimated county-level prevalence of selected underlying medical conditions associated with increased risk. Morb. Mortal. Wkly. Rep 69, 945&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7377821</ArticleId><ArticleId IdType="pubmed">32701937</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes EK, Zambrano LD, Anderson KN, Marder EP, Raz KM, Felix SEB, et al., 2020. Coronavirus disease. Morb. Mortal. Wkly. Rep 69, 759&#x2013;765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7302472</ArticleId><ArticleId IdType="pubmed">32555134</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al., 2021. Attributes and predictors of long COVID. Nat. Med 27 (4), 626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Driessche P, Watmough J, 2002. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci 180, 29&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">12387915</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker JL, Grint DJ, Strongman H, Eggo RM, Peppa M, Minassian C, et al., 2021. UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: A point prevalence study using electronic health records. BMC Public Health 21, 484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948667</ArticleId><ArticleId IdType="pubmed">33706738</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, 2020. Mathematical models for COVID-19: Applications, limitations, and potentials. J. Public Health Emerg 4, 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386428</ArticleId><ArticleId IdType="pubmed">32724894</ArticleId></ArticleIdList></Reference><Reference><Citation>Willi S, L&#xfc;thold R, Hunt A, et al., 2021. COVID-19 sequelae in adults aged less than 50 years: a systematic review. Travel Med. Infect. Dis 40, 101995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898978</ArticleId><ArticleId IdType="pubmed">33631340</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Wang J, 2021. COVID-19 and underlying health conditions: A modeling investigation. Math. Biosci. Eng 18 (4), 3790&#x2013;3812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8359646</ArticleId><ArticleId IdType="pubmed">34198413</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>